PBIRx®
Intelligent Solutions in Pharmacy Benefits
On Friday, March 31,
the FDA alerted consumers to the voluntary recall of 13 lots of Mylan's EpiPen
and EpiPen Jr Auto-Injector products that are used for emergency treatment of
severe allergic reactions. The recalled products were distributed from
December 2015 through July 2016. These
devices may contain a defective part that could result in its failure to activate.
This recall impacts the 0.3mg and 0.15mg strengths.
Consumers should keep
and use their current EpiPen products, if needed, until they get a replacement.
If you have a recalled EpiPen product, contact Stericycle to provide a container
to return the recalled medication. You
will also receive a voucher to redeem for a free replacement product. Please contact Stericycle at 877-650-3494.
If you have any
questions or concerns, contact Mylan Customer Relations at 800-796-9526 or at customerservice@mylan.com .
PBIRx has notified
all clients and brokers of this recall and will always be proactive to our
consumers when we receive important pharmacy information that may impact their
health.
PBIRx has
been exclusively providing intelligent solutions to clients in the management
of pharmacy benefit costs since 1993. With a staff that includes IT personnel,
actuaries, financial analysts, clinical pharmacists, attorneys, HIPAA
Compliance Officers and many more experts, PBIRx’s mission is to create optimal
health care outcomes while minimizing overall health care costs. For more
information, please visit www.pbirx.com or call (888) 797-2479.
No comments:
Post a Comment